-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Valganciclovir hydrochloride is an antiviral drug that is commonly used to treat herpes zoster (shingles) and herpes simplex infections.
It is also sometimes used to prevent cytomegalovirus (CMV) infection in people who have received organ transplants.
The drug is a synthetic analog of the naturally occurring compound ganciclovir, which is derived from the herb "Laportea contorta.
" Synthetic routes for valganciclovir hydrochloride have been developed over the years, and these routes have improved the efficiency and cost-effectiveness of the drug's production.
The synthesis of valganciclovir hydrochloride involves several steps, including the synthesis of the parent compound, 2-amino-9-(1,3-oxazolidin-3-yl) 8H-pyrido[1,2-d]pyrimidin-6-one, and its conversion to valganciclovir.
The first step in the synthesis of valganciclovir hydrochloride is the preparation of the starting material, which is usually achieved through the reduction of 2,4-dihydroxy-5-methyl-1,3-oxazolidin-3-one.
This reduced derivative is then treated with methyl iodide to form the methyl ether, which is subsequently reduced with lithium aluminum hydride (LiAlH4) to produce the alcohol.
The next step involves the treatment of the alcohol with 1,3-oxazolidine-2,4-dione to form the desired compound, 2-amino-9-(1,3-oxazolidin-3-yl) 8H-pyrido[1,2-d]pyrimidin-6-one.
The final step in the synthesis of valganciclovir hydrochloride is the conversion of the parent compound into the desired drug.
This involves the treatment of the parent compound with chloroform and a base, such as sodium hydroxide, to form the sodium salt.
The resulting salt is then treated with hydrochloric acid to form the hydrochloride salt, which is the final product.
The synthetic routes for valganciclovir hydrochloride have been improved over the years to increase efficiency and reduce costs.
One such improvement is the use of nucleophilic substitution reactions to synthesize the alcohol and the parent compound.
This method involves the use of reagents such as methyl iodide, 1,3-oxazolidine-2,4-dione, and sodium hydroxide, which are more readily available and less expensive than the reagents used in earlier synthetic routes.
Another improvement in the synthesis of valganciclovir hydrochloride involves the use of microwave irradiation to accelerate the reaction times.
Microwave irradiation has been shown to significantly reduce the reaction times and increase the yield of the desired product.
This method has been found to be particularly effective for the synthesis of valganciclovir hydrochloride, as it allows for the efficient formation of the hydrochloride salt in a short period of time.
The synthetic routes for valganciclovir hydrochloride have also been improved through the use of green chemistry principles.
Green chemistry is a philosophy that encourages the design of chemical products and processes that minimize waste and the use of hazardous substances.
One example of a green synthetic route for valganciclovir hydrochloride involves the use of an environmentally friendly solvent, such as ethanol, instead of chloroform.
This method not only reduces the amount of toxic solvents used in the synthesis, but it also increases the yield of the desired product.
In conclusion, the synthetic routes for valganciclovir hydrochloride have been